B1 Other refereed article (e.g., editorial, letter, comment) in a scientific journal
The impact of the patient macroenvironment on molecular subgroups in endometrial cancer
Authors: Werner, Henrica M. J.; van Dijk, Frederiek A. H.; Vrede, Stephanie W.; van den Bosch, Anouk A. S.; Lombaers, Marike S.; Asberger, Jasmin; Huvila, Jutta; Snijders, Marc; Tubita, Valeria; Moreno Mancebo, Gemma; Matias-Guiu, Xavier; Bretová, Petra; ENITEC Consortium; Weinberger, Vit; Pijnenborg, Johanna M. A.
Publisher: Wiley
Publication year: 2026
Journal: Cancer
Article number: e70333
Volume: 132
Issue: 6
ISSN: 0008-543X
eISSN: 1097-0142
DOI: https://doi.org/10.1002/cncr.70333
Publication's open availability at the time of reporting: Open Access
Publication channel's open availability : Partially Open Access publication channel
Web address : https://doi.org/10.1002/cncr.70333
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/516035731
Self-archived copy's licence: CC BY NC ND
Self-archived copy's version: Publisher`s PDF
More than half of endometrial cancer diagnoses can be attributed to obesity. A purely molecular classification in endometrial cancer hampers further understanding of the impact of patient macroenvironment as a major risk factor. The relationship between patient factors, such as age, body mass index (BMI), comorbidity, and ethnicity, and molecular subgroups was studied in a publicly available data set (N = 225) and two multicenter European cohorts (N = 223; N = 946). Age at diagnosis was highest in the TP53-mutated subgroup, and differed significantly between molecular subgroups. Patients with obesity were younger at diagnosis compared to their lean counterparts across all molecular subgroups (61.9 vs. 66.2 years; p <.01). Survival was worst in the TP53-mutated subgroup but improved with increasing BMI, which resulted in nonsignificant differences from other subgroups when BMI was >35. These data underscore that patient factors remain important, and their integration with molecular factors needs to be better understood to ultimately improve treatment and prevention strategies in endometrial cancer.
Downloadable publication This is an electronic reprint of the original article. |  |
